Clinical Trials

NCT IdNCT04107441
TitleAX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
OrganizationAxalbion SA
Sponsor/CollaboratorsAxalbion SA
StatusActive, not recruiting
Location (with distance)
  • Medicines Evaluation Unit (MEU) Ltd, Manchester, M23 9QZ , United Kingdom
DescriptionThe main purpose of the study is to see how safe the study drug AX-8 is and how well it is tolerated when administered at different dose levels in healthy participants. The study will also investigate pharmacokinetics (PK), i.e how the study drug is taken up, metabolized (broken down) and eliminated.